Stereospecific synthesis of (2S)-2-methyl-3-(2',6'-dimethyl-4'-hydroxyphenyl)-propionic acid (Mdp) and its incorporation into an opioid peptide

Bioorg Med Chem Lett. 2001 Feb 12;11(3):323-5. doi: 10.1016/s0960-894x(00)00660-0.

Abstract

To examine the effect of replacing the N-terminal amino group in opioid peptides with a methyl group on biological activity, a stereospecific synthesis of the tyrosine analogue (2S)-2-methyl-3-(2',6'-dimethyl-4'-hydroxyphenyl)-propionic acid (Mdp) was performed. The enkephalin analogue (2S)-Mdp-D-Ala-Gly-Phe-Leu-NH2 turned out to be a quite potent delta opioid antagonist and a somewhat less potent mu antagonist, indicating that a positively charged N-terminal amino group is not a conditio sine qua non for the binding of opioid peptides to delta and mu receptors but may be required for signal transduction.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Brain
  • Enkephalins / chemical synthesis
  • Enkephalins / pharmacology
  • Guinea Pigs
  • Ileum / drug effects
  • Inhibitory Concentration 50
  • Male
  • Membranes / chemistry
  • Mice
  • Muscle Contraction / drug effects
  • Opioid Peptides / chemical synthesis*
  • Opioid Peptides / metabolism
  • Opioid Peptides / pharmacology
  • Phenols
  • Propionates / chemical synthesis
  • Propionates / pharmacology*
  • Protein Binding
  • Rats
  • Receptors, Opioid, delta / antagonists & inhibitors*
  • Receptors, Opioid, delta / metabolism
  • Receptors, Opioid, mu / antagonists & inhibitors
  • Receptors, Opioid, mu / metabolism
  • Stereoisomerism
  • Structure-Activity Relationship
  • Vas Deferens / drug effects

Substances

  • 2-methyl-3-(2',6'-dimethyl-4'-hydroxyphenyl)-propionic acid
  • Enkephalins
  • Opioid Peptides
  • Phenols
  • Propionates
  • Receptors, Opioid, delta
  • Receptors, Opioid, mu